ID   ARK72_RAT               Reviewed;         367 AA.
AC   Q8CG45; Q6P765; Q8K435; Q9JM82;
DT   15-DEC-2003, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-2003, sequence version 2.
DT   24-JUL-2024, entry version 144.
DE   RecName: Full=Aflatoxin B1 aldehyde reductase member 2;
DE            Short=rAFAR2;
DE            EC=1.1.1.n11;
DE   AltName: Full=Succinic semialdehyde reductase;
DE            Short=SSA reductase;
DE   Flags: Precursor;
GN   Name=Akr7a2; Synonyms=Afar2, Aiar;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 4-14 AND 33-44, FUNCTION,
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RC   STRAIN=Fischer 344; TISSUE=Liver;
RX   PubMed=12071861; DOI=10.1042/bj20020342;
RA   Kelly V.P., Sherratt P.J., Crouch D.H., Hayes J.D.;
RT   "Novel homodimeric and heterodimeric rat gamma-hydroxybutyrate synthases
RT   that associate with the Golgi apparatus define a distinct subclass of aldo-
RT   keto reductase 7 family proteins.";
RL   Biochem. J. 366:847-861(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 11-367.
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 11-367.
RX   PubMed=12879023; DOI=10.1038/sj.onc.1206684;
RA   Praml C., Savelyeva L., Schwab M.;
RT   "Aflatoxin B1 aldehyde reductase (AFAR) genes cluster at 1p35-1p36.1 in a
RT   region frequently altered in human tumour cells.";
RL   Oncogene 22:4765-4773(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 12-367.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=10965890; DOI=10.1210/endo.141.9.7685;
RA   Nishi N., Shoji H., Miyanaka H., Nakamura T.;
RT   "Androgen-regulated expression of a novel member of the aldo-keto reductase
RT   superfamily in regrowing rat prostate.";
RL   Endocrinology 141:3194-3199(2000).
RN   [5]
RP   PROTEIN SEQUENCE OF 230-244; 259-269 AND 306-317, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Spinal cord;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (NOV-2006) to UniProtKB.
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Catalyzes the NADPH-dependent reduction of succinic
CC       semialdehyde to gamma-hydroxybutyrate. May have an important role in
CC       producing the neuromodulator gamma-hydroxybutyrate (GHB). Has broad
CC       substrate specificity. Can reduce the dialdehyde protein-binding form
CC       of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. Acts as a 2-
CC       carboxybenzaldehyde reductase. {ECO:0000269|PubMed:12071861}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=4-hydroxybutanoate + NADP(+) = H(+) + NADPH + succinate
CC         semialdehyde; Xref=Rhea:RHEA:26381, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16724, ChEBI:CHEBI:57706, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349; EC=1.1.1.n11;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=Has a low KM for succinic semialdehyde.;
CC   -!- SUBUNIT: Homodimer. Heterodimer with AKR7A1.
CC       {ECO:0000269|PubMed:12071861}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000255}. Golgi apparatus,
CC       Golgi stack {ECO:0000269|PubMed:12071861}. Cytoplasm
CC       {ECO:0000269|PubMed:12071861}. Note=Its association with the Golgi
CC       stack may facilitate secretion of GHB. {ECO:0000303|PubMed:12071861}.
CC   -!- MISCELLANEOUS: With 4-nitrobenzaldehyde as substrate, it exhibits a
CC       substantially greater specific activity with NADPH than with NADH.
CC       Conversely, it has a 1.8-fold higher activity towards succinic
CC       semialdehyde with NADH than with NADPH.
CC   -!- SIMILARITY: Belongs to the aldo/keto reductase family. Aldo/keto
CC       reductase 2 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH61816.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA90396.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAC81080.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF503514; AAN03824.1; -; mRNA.
DR   EMBL; BC061816; AAH61816.1; ALT_INIT; mRNA.
DR   EMBL; AJ271883; CAC81080.1; ALT_INIT; mRNA.
DR   EMBL; AB037424; BAA90396.1; ALT_INIT; mRNA.
DR   RefSeq; NP_599234.1; NM_134407.1.
DR   AlphaFoldDB; Q8CG45; -.
DR   SMR; Q8CG45; -.
DR   BioGRID; 251255; 1.
DR   STRING; 10116.ENSRNOP00000024063; -.
DR   iPTMnet; Q8CG45; -.
DR   PhosphoSitePlus; Q8CG45; -.
DR   jPOST; Q8CG45; -.
DR   PaxDb; 10116-ENSRNOP00000024063; -.
DR   Ensembl; ENSRNOT00055039859; ENSRNOP00055032343; ENSRNOG00055023191.
DR   Ensembl; ENSRNOT00060046893; ENSRNOP00060038995; ENSRNOG00060027035.
DR   Ensembl; ENSRNOT00065037964; ENSRNOP00065030718; ENSRNOG00065022270.
DR   GeneID; 171445; -.
DR   KEGG; rno:171445; -.
DR   UCSC; RGD:620311; rat.
DR   AGR; RGD:620311; -.
DR   CTD; 8574; -.
DR   RGD; 620311; Akr7a2.
DR   eggNOG; ENOG502QU2T; Eukaryota.
DR   InParanoid; Q8CG45; -.
DR   OrthoDB; 1379250at2759; -.
DR   PhylomeDB; Q8CG45; -.
DR   TreeFam; TF329173; -.
DR   Reactome; R-RNO-5423646; Aflatoxin activation and detoxification.
DR   SABIO-RK; Q8CG45; -.
DR   PRO; PR:Q8CG45; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005795; C:Golgi stack; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005635; C:nuclear envelope; IDA:RGD.
DR   GO; GO:0004033; F:aldo-keto reductase (NADPH) activity; IBA:GO_Central.
DR   GO; GO:0004032; F:aldose reductase (NADPH) activity; IDA:RGD.
DR   GO; GO:0019119; F:phenanthrene-9,10-epoxide hydrolase activity; ISO:RGD.
DR   GO; GO:0044597; P:daunorubicin metabolic process; ISO:RGD.
DR   GO; GO:0044598; P:doxorubicin metabolic process; ISO:RGD.
DR   GO; GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW.
DR   CDD; cd19075; AKR_AKR7A1-5; 1.
DR   Gene3D; 3.20.20.100; NADP-dependent oxidoreductase domain; 1.
DR   InterPro; IPR050523; AKR_Detox_Biosynth.
DR   InterPro; IPR023210; NADP_OxRdtase_dom.
DR   InterPro; IPR036812; NADP_OxRdtase_dom_sf.
DR   PANTHER; PTHR43364:SF4; NAD(P)-LINKED OXIDOREDUCTASE SUPERFAMILY PROTEIN; 1.
DR   PANTHER; PTHR43364; NADH-SPECIFIC METHYLGLYOXAL REDUCTASE-RELATED; 1.
DR   Pfam; PF00248; Aldo_ket_red; 1.
DR   SUPFAM; SSF51430; NAD(P)-linked oxidoreductase; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cytoplasm; Direct protein sequencing; Golgi apparatus;
KW   Lipid metabolism; Mitochondrion; NADP; Oxidoreductase; Phosphoprotein;
KW   Reference proteome; Transit peptide.
FT   TRANSIT         1..46
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           47..367
FT                   /note="Aflatoxin B1 aldehyde reductase member 2"
FT                   /id="PRO_0000070377"
FT   REGION          27..46
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        85
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250"
FT   BINDING         80
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         149
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         179..180
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         205
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         234..244
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         258
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         268
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         271
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         326..334
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /evidence="ECO:0000250"
FT   BINDING         367
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   SITE            113
FT                   /note="Lowers pKa of active site Tyr"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CG76"
FT   MOD_RES         48
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CG76"
FT   MOD_RES         136
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CG76"
FT   MOD_RES         244
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CG76"
FT   MOD_RES         263
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CONFLICT        136
FT                   /note="K -> N (in Ref. 1; AAN03824)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        295
FT                   /note="S -> D (in Ref. 1; AAN03824)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        299..300
FT                   /note="MT -> ND (in Ref. 3; CAC81080)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   367 AA;  40675 MW;  AA27A3FBB454FEC5 CRC64;
     MLRAVSRAVS RAAVRCAWRS GPSVARPLAM SRSPAPRAVS GAPLRPGTVL GTMEMGRRMD
     ASASAATVRA FLERGLNELD TAFMYCDGQS ESILGSLGLG LGSGDCTVKI ATKANPWDGK
     SLKPDSVRSQ LETSLKRLQC PRVDLFYLHA PDHGTPIVET LQACQQLHQE GKFVELGLSN
     YASWEVAEIY TLCKSNGWIL PTVYQGMYNA TTRQVETELL PCLRYFGLRF YAYNPLAGGL
     LTGKYRYEDK DGKQPEGRFF GNSWSETYRN RFWKEHHFEA IALVEKALKT TYGTSAPSMT
     SAALRWMYHH SQLQGTRGDA VILGMSSLEQ LEQNLAATEE GPLEPAVVEA FNQAWNVVAH
     ECPNYFR
//
